Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  35.00 6.06% 613.00 612.00 617.00 633.00 613.00 625.00 171,680 08:58:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 166.7 -138.8 -13.2 - 4,564

Hutchmed (china) Share Discussion Threads

Showing 3426 to 3448 of 3450 messages
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
29/7/2021
09:04
Closing around 76HK.Our AIM marketmakers continue to pay homage to the nasdaq quote.The AIM marketmakers could well be short.There's a real reluctance to follow the HK price hike and that sometimes indicates a desire to hose down enthusiasm until they get square ie a bit like Goldmans refusing to correctly price subprime in 2008 until they themselves were short.Speculation on my part.I appreciate the AIM market affording buying opportunities.
steeplejack
29/7/2021
07:45
It’ll be interesting to see how our marketmaker trojans on the AIM market open up this morning.(On Monday,they marked the stock down to 535p).The US closed last night at £6 equivalent but with the HK quote now over 76HK,up over 15%,thats around 706p equivalent.I suppose they’ll split the difference and open up around 650p.
steeplejack
29/7/2021
07:04
P/S and other metrics finally on a par with Innovent and Beigene. The Company said clearly yesterday they will be a large global Biopharma by 2025. Revenues will be far in excess of $1bn by then and they should be cashflow positive too.
nerdofsteel
29/7/2021
06:46
Stock currently back over 73HK +10%,673p equivalent.
steeplejack
28/7/2021
17:11
Both the webcast and, especially, the interims came after HK closed Https://www.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote?sym=13&sc_lang=en . 650p tomorrow??
mcmather
28/7/2021
12:38
Brilliant set of results - great example of progress · ELUNATE® (fruquintinib in China) in-market sales increased 186% to $40.1 million (H1-20: $14.0m $20bn+ mcap by 2025
nerdofsteel
28/7/2021
12:16
Almost 10% difference between hk close and uk price. Some smart guy with the right market access is going to clean up , even with exchange rate differences surely has to be a clear 5% no risk gain?
dbadvn
28/7/2021
12:02
HUTCHMED Reports 2021 Interim Results and Provides Business Updates ELUNATE® in-market sales1 rose 186%, reflecting impact of in-house sales force Received 1st approval in China for ORPATHYS® and 2nd approval in China for SULANDA® U.S. and E.U. applications for surufatinib both accepted Raised $615m2 gross proceeds from additional listing on HKEX3 Company to Host Interim Results Call & Webcast Today at 8 p.m. HKT / 1 p.m. BST / 8 a.m. EDT
lauders
28/7/2021
05:33
5% up in HK so far on this news: HUTCHMED (China) Limited (“HUTCHMED”) and AstraZeneca PLC (“AstraZeneca”) (LSE/STO/Nasdaq: AZN) have initiated a Phase II study of ORPATHYS® (savolitinib), an oral, potent, and highly selective small molecule inhibitor of MET, a receptor tyrosine kinase, in patients with advanced or metastatic MET amplified gastric cancer (“GC”) or adenocarcinoma of the gastroesophageal junction (“GEJ”). The first patient was dosed on July 27, 2021. Https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0728/2021072800035.pdf
lauders
26/7/2021
16:07
I've done it before for the AIM and NASDAQ but the Broker currency charges make it almost impossible to get a decent return
nerdofsteel
26/7/2021
13:34
Surely there must be a smart trader somewhere who can arbitrage an almost 10% difference between HK and UK Aim?
dbadvn
26/7/2021
10:01
Results Update this week on 28th so we will see this week. 12 noon Uk time
chester9
26/7/2021
09:14
Is the last RNS going to be a drag on the recent good momentum? Looks like it could be. Shame, we were doing so much better. Long term I am sure we will still do better. Can't keep going up.
lauders
26/7/2021
09:12
625 equivalent close in HK.Prompting,no doubt,the AIM trading books to have a bid price 10% lower at 565p.Childlike rather than insightful.
steeplejack
23/7/2021
15:24
Fri, 23rd Jul 2021 12:01RNS Number : 3134GHutchmed (China) Limited23 July 2021 Stabilizing Actions and End of Stabilization Period in connection with the Global Offering Hong Kong, Shanghai & Florham Park, NJ - Friday, July 23, 2021: HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM: HCM; HKEX: 13) announces that the stabilization period in connection with the Global Offering ended on July 23, 2021, being the 30th day after the last day for the lodging of applications under the Hong Kong Public Offering on June 23, 2021. The stabilizing actions undertaken by Morgan Stanley Asia Limited, as the Stabilizing Manager (or any person acting for it) during the stabilization period were: (1) over-allocations of an aggregate of 15,600,000 Offer Shares in the International Offering, representing approximately 15% of the total number of the Offer Shares initially available under the Global Offering before any exercise of the Over-allotment Option; (2) borrowing of an aggregate of 15,600,000 Shares by Morgan Stanley & Co. International plc (an affiliate of Morgan Stanley Asia Limited) from Hutchison Healthcare Holdings Limited (an indirect wholly-owned subsidiary of CK Hutchison Holdings Limited) pursuant to the Stock Borrowing Agreement dated June 23, 2021, to cover over-allocations in the International Offering; and (3) the full exercise of the Over-allotment Option by the Joint Global Coordinators, on behalf of the International Underwriters, on July 12, 2021, in respect of an aggregate of 15,600,000 Offer Shares, representing approximately 15% of the total number of the Offer Shares initially available under the Global Offering before any exercise of the Over-allotment Option, at the Offer Price, to facilitate the return to Hutchison Healthcare Holdings Limited of all the borrowed Shares under the Stock Borrowing Agreement which were used to cover over-allocations in the International Offering. There has been no purchase or sale of any Shares on the market for the purpose of price stabilization by the Stabilizing Manager during the stabilization period.
chester9
23/7/2021
08:58
Agree with your assessments. I am assuming there will be some ‘pressure̵7; on the LT holders to sell, perhaps until the results day which is on 28/7. Having seen the cornerstone investors putting huge sums into this company during the recent weeks and months, I too feel like staying here for bit longer.
sportii
23/7/2021
08:21
indeed. This will be a $20bn+ Company by 2025 in my opinion and will generate lots of cash.
nerdofsteel
22/7/2021
18:14
HM cashed up through to cash break even and will be flooded with cash over the next 2-3 years That's why the bigger investors came on board ( and HK listing of course ). These guys are looking for 2-3 times their original investment over 3 - 5 years and they do their homework. So I'm staying along for the ride. Now a 14 bagger for me ....!!!
dbadvn
22/7/2021
17:45
Will continue to be a long-term hold. I'm nearing retirement so my portfolio has become quite low risk - by my standards, anyway. I've lost a couple of hundred thousand over the years on crazy high-risk stocks. At the age of 60 I've finally realised that greed is the enemy, slow and steady rises in companies with sound fundamentals are the answer. I feel Chi-med is one of these, just a bit concerned about anti-Chinese sentiment spilling over into the markets.
nahoon
22/7/2021
13:20
Nice, you tempted to sell? Dare I say it but longer term chart looks good to me for a run to 750p. Fingers crossed.
its the oxman
22/7/2021
09:45
Anyone got any near term price insights here, went to 650p briefly on its initial spike after HK listing. So kind of expect it to revisit that as a minimum given more positive momentum now.
its the oxman
21/7/2021
08:32
Yes,having been through the rapids,i won’t be chopping out my canoe now that we appear to be in such benign waters.Will simply enjoy the ride. Back in the late 90’s my architect brother in law held a reasonable quantity of Apple shares,around £25,000 worth.(Used the Apple graphics technology in his business).He sold his shares for a goodly profit but reflects to this day that if he’d simply held on,his holding would now be worth a short £3m.Thereagain,many a tale relates opposite experiences as we know from the tech boom 20 years back.Stockmarket investment is incapable of delivering nirvana.
steeplejack
21/7/2021
08:19
Could have been worse steeplejack. Just think what you would be saying if you sold up completely? Things are look much better since the HK listing and the future will no doubt be bright for the patient! I plan to just hold what I have now for years to come and see the story, as well as share price, improve. What's the betting both will not be reality?
lauders
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
ADVFN Advertorial
Your Recent History
LSE
HCM
Hutchmed (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210729 08:16:29